CARsgen® to Present Zevor-cel, CT071 and CT0590 at ASH 2024 Annual Congress
- Written by PR Newswire
![]() |
SHANGHAI, Nov. 6, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the Company will present the clinical data of zevorcabtagene autoleucel, CT071, and CT0590 as posters at the 66th...
Read more: CARsgen® to Present Zevor-cel, CT071 and CT0590 at ASH 2024 Annual Congress















